Sanofi to help manufacture pending J&J Covid-19 vaccine
Company says it will be able to produce an estimated 12 million doses per month
Pelican BioThermal signs on new distributors
Pair of agreements expands packaging company's international network
EMA launches IDMP Implementation Guide
While clock now ticking for life sciences companies to comply with the new data standards, opportunities in the offing to simplify manufacturing and the supply chain
Kuehne+Nagel buys Asian freight forwarder giant Apex
Acquisition is 3PL provider's largest one yet
Antares Vision purchases rfXcel Corporation for $120M
Acquisition grows Antares’ track-and-trace presence
Cell and gene therapy: A recipe for resiliency
The importance of thinking strategically about the infrastructure and foresight needed to scale up CGTs—not as treatments of last resort, but first choice
Charles River Laboratories acquires Cognate BioServices for $875M
Strengthens the CRO's scientific capabilities in cell and gene therapy space
CDMO Regis Technologies doubles its capacity
Lab development project features 9,000-square-foot expansion
GSK and Vir Biotechnology expand R&D collaboration
Combine their expertise in immunology and infectious diseases to speed up development of mAbs for influenza
Pfizer/BioNTech and Moderna to supply EU with more doses
Between both Covid-19 vaccines, an additional 350 million doses are being sent to Europe this year
The CM Group bolsters presence in life sciences sector
Acquires Scientific Commercialization, a medical affairs consulting and analytics business
WHO green-lights AstraZeneca’s vaccine for emergency use
Authorization should activate distribution of hundreds of millions of doses to countries involved with COVAX effort
Navitus Health Solutions acquires CareMetx’s specialty pharmacy
PBM's own specialty pharmacy unit adds CareMetx Health, growing its coverage base to the eastern US
Tribe expands fleet with Carrier refrigeration products
Deal will help expand its pharma presence
PwC joins Medicines Manufacturing Innovation Centre
Becomes a partner in UK consortium focused on enabling new and disruptive manufacturing technologies
Rentschler Biopharma launches Center of Excellence
UK cell and gene therapy location expected to be cGMP-ready by mid-2022
HKSTP, AstraZeneca introduce biotech incubator program
Will help biomed startups in furthering oncology R&D
Lilly's Covid-19 antibody cocktail granted EUA
There are currently 100,000 doses standing by
Sonoco ThermoSafe conducts successful ULD test shipment
Results address concerns surrounding bulk passive pharma packaging
Orphan drug manufacturers struggle with data management, report finds
Survey of orphan drug commercial operation leaders gives glimpse into market challenges
Pfizer says it will cut vaccine production time almost in half
As efficiencies increase, company aims to cut time from 110 to about 60 days, according to a published report
South Africa pauses plan of utilizing AstraZeneca vaccine
Report: After data displayed minimal effectiveness, government pauses vaccine rollout
IATA unveils 2020 air freight data
Last year’s numbers indicate historic lows
GSK and CureVac partner up to develop future mRNA Covid-19 vaccines
$180M collaboration aims to introduce multiple vaccine candidates in 2022
Ocugen and Bharat Biotech reach vaccine commercialization agreement for US market
Two-dose COVAXIN currently under EUA in India
SGD Pharma granted platinum EcoVadis mark
Rating for packaging supplier highlights its commitment to sustainable practices and corporate social responsibility
WuXi STA expands to Europe with purchase of BMS facility
CDMO to take over operations, including equipment and workforce, at site in Couvet, Switzerland
Verista acquires Hawkins Points
Deal completes Verista's lifecycle support for pharma, which now includes consulting, technology and manufacturing
URAC and Acentrus Specialty sign patient care partnership
Agreement provides Acentrus with specialty pharmacy accreditation
AstraZeneca increases EU’s Q1 vaccine estimate to 40M
Following last week's announcement of supply decrease, company raises projection by 9 million
